[Background of vaccine] 

The Cuban Academy of Sciences provides vaccines Vaxira and CIMAvax for the treatment of non-small cell lung cancer.

This newest vaccine for the treatment of NSCLC has been proven in Phase 3 clinical trials and has a good impact on non-small cell lung cancer and is now in clinical applications in Cuba and Peru. This exciting study is the latest anticancer technology that former US President Barack Obama lifted for 55 years and then introduced it to the United States in 2015.

The US Food and Drug Administration (FDA) has approved a clinical trial of a US-developed lung cancer vaccine that can stimulate the immune system of Cuban-developed lung cancer patients.

[Cost]

The vaccine cost for 6 months is about 10 million won, and there is extra extra cost.

[Prescription] 

You can connect with the hospital through HK HIS.